Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction

Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Dongryul, Park, Hee Chul, Lim, Ho Yeong, Yoo, Byung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797277/
https://www.ncbi.nlm.nih.gov/pubmed/24137563
http://dx.doi.org/10.3857/roj.2013.31.3.171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797277/
https://www.ncbi.nlm.nih.gov/pubmed/24137563
http://dx.doi.org/10.3857/roj.2013.31.3.171

Ejemplares similares